Tech Company Financing Transactions
Cornerstone Pharmaceuticals Funding Round
Cornerstone Pharmaceuticals closed a $4.6 million investment round on 4/1/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
4/1/2013
Transaction Type
Debt
Amount
$4,565,110
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Duncan Dr.
Cranbury, NJ 08512
USA
Cranbury, NJ 08512
USA
Phone
Website
Email Address
Overview
Cornerstone's experienced management team has a long and successful track record of discovering and developing novel therapeutics and of leading successful entrepreneurial life sciences ventures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Shorr
Chief Financial Officer
Clifford Straub
VP - General Counsel
David Polinsky
VP - R & D
Paul Bingham
VP - Regulatory Affairs
King Lee
Browse more venture capital transactions:
Prev: 4/1/2013: TherOx venture capital transaction
Next: 4/2/2013: Proximal Data venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs